“…It shows strong cytotoxic activity against a broad‐spectrum of cancer cell lines at the cellular level, and is effective in the treatment of wilms tumors, various genital tumors, non‐Hodgkin's lymphomas, and lung cancer (Imbert, ; Subrahmanyam et al., ; Utsugi et al., ). Etoposide, teniposide, and etopophos are used clinically for the treatment of various types of malignancies (Chernysheva et al., ; Kamal et al., ; Reddy, Srinivas, Chashoo, Saxena, & Kumar, ), especially for the small‐cell lung cancer, non‐Hodgkin's lymphoma, testicular carcinoma, leukemia, and kaposi's sarcoma (Duca et al., ). However, their clinical use has encountered certain limitations such as metabolic inactivation, development of drug resistance, and certain toxic effects (Kobayashi & Ratain, ).…”